# "Real Life" Evaluation of Efficacy and Safety of Direct Antiviral Agents (DAAs) for the Treatment of Hepatitis C Virus in Egypt

> **NCT03510637** · — · UNKNOWN · sponsor: **ANRS, Emerging Infectious Diseases** · enrollment: 7500 (estimated)

## Conditions studied

- Chronic Hepatitis C

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03510637
- **Lead sponsor:** ANRS, Emerging Infectious Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-22
- **Primary completion:** 2020-08
- **Final completion:** 2020-08
- **Target enrollment:** 7500 (ESTIMATED)
- **Last updated:** 2019-07-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03510637

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03510637, ""Real Life" Evaluation of Efficacy and Safety of Direct Antiviral Agents (DAAs) for the Treatment of Hepatitis C Virus in Egypt". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03510637. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*